Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance

Novo Nordisk's Wegovy pill sales exceeded forecasts after its launch, leading to raised guidance for 2026. The strong performance of the newly launched pill contributed to the company's improved outlook. This increase in sales and guidance boost indicates a successful start for the product.